Product Information
DICLOFENAC SODIUM 3% GEL is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3679 per GM under NDC 45802011101. Its NADAC has been published 405 times since Jan 2, 2019.
FDA first approved this application on Jul 27, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802011101
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA210893FDA Approved
7/27/2018
TE Code
AB
On Market Since
11/27/2018
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC SODIUM 3% GEL has been published 405 times since Jan 2, 2019, and over the history we have for it it has declined 54.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3679 per GM |
|---|---|
| All-time high | $0.8457 (Feb 13, 2019) |
| All-time low | $0.3077 (Apr 17, 2024) |
| 52-week high | $0.3862 |
| 52-week low | $0.3573 |
| Median price | $0.4227 |
| Average price | $0.4504 |
| Largest weekly change | +46.5% (Aug 23, 2023) |
| Weeks tracked | 405 |
| Tracking since | Jan 2, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
diclofenac sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC SODIUM 3% GEL?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC SODIUM 3% GEL, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3679 per GM (NDC 45802011101), effective Sep 30, 2026.
How has the price of DICLOFENAC SODIUM 3% GEL changed over time?
Over the history we have for it, the NADAC for DICLOFENAC SODIUM 3% GEL has declined 54.8%. It has been tracked across 405 weekly CMS publications since Jan 2, 2019.
What are the highest and lowest recorded NADAC prices for DICLOFENAC SODIUM 3% GEL?
Since Jan 2, 2019, the NADAC for DICLOFENAC SODIUM 3% GEL has ranged from a low of $0.3077 (Apr 17, 2024) to a high of $0.8457 (Feb 13, 2019), with a median of $0.4227 per GM.
Are there cheaper alternatives to DICLOFENAC SODIUM 3% GEL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DICLOFENAC SODIUM 3% GEL in a comparable dosage form, but none are currently priced below it.
Who manufactures DICLOFENAC SODIUM 3% GEL?
DICLOFENAC SODIUM 3% GEL (NDC 45802011101) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.